EGEN's Unattributed Round

EGEN raised a round of funding on October 25, 2013.

EGEN, with laboratories and headquarters in Huntsville, Alabama, is a privately held clinical stage biopharmaceutical company focused on developing therapeutics for the treatment of human diseases. EG…

Articles about EGEN's Unattributed Round: